A pharmaceutical company that combines probiotics with synthetic biology to create novel therapeutics for chronic diseases. The underlying concept of their strategies is to used genetically engineered probiotic bacteria as vectors for the delivery of therapeutic proteins for the treatment of inflammatory bowel disease.